Broken String Biosciences (“Broken String”), a leader in advancing gene editing safety, today opened its Catalyst Early Access Program (EAP) for developers of gene-edited therapies that allow for the ...
BOSTON & CAMBRIDGE, England, August 05, 2025--(BUSINESS WIRE)--Broken String Biosciences ("Broken String"), a leader in advancing gene editing safety, today announced its formal re-engagement as a ...
Eurostar grant supports application of BioLizard’s AI expertise to Broken String’s INDUCE-seq® platform Resulting technology, called SafeGuide, will enable faster, more cost-effective development of ...
- Research published in Molecular Cell used INDUCE-seq to identify DNA topology as an important regulator of CRISPR targeting specificity - Peer-reviewed data demonstrates the sensitivity of ...
Broken String Biosciences (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced that its ...